Dyne Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)
Go back to Dyne Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)| DYNEGY, Inc. (NASDAQ: DYN) | Delayed: 26.10 +0.12 (0.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.98 | 52 Week High | $22.01 | |||
| Open | $26.22 | 52 Week Low | $7.01 | |||
| Day High | $26.87 | P/E | N/A | |||
| Day Low | $26.02 | EPS | $0.00 | |||
| Volume | 1,181,848 | |||||
